Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Oct 25, 2021 07:05 ET
HBT Financial, Inc. Announces Third Quarter 2021 Financial Results
HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial” or “HBT”), the holding company for Heartland Bank and Trust Company and NXT Bank, today reported net income of $13.7 million, or $0.50 diluted earnings per share, for the third...
Oct 25, 2021 07:05 ET
uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the third quarter of 2021 and highlighted recent progress across its...
Oct 25, 2021 07:04 ET
Tier-1 Mobile Operator in Asia Expands 4G Network with Gilat's Cellular Backhaul Solution
Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that a Tier-1 mobile operator in Asia expanded its 4G network with Gilat's cellular backhaul...
Oct 25, 2021 07:00 ET
AC Immune to Present at the Jefferies London Healthcare Conference
AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company management will participate in a fireside chat and one-on-one investor meetings...
Oct 25, 2021 07:00 ET
Akoustis to Webcast Q1FY22 Results on November 1st at 8:00 am ET
Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, will webcast its Q1FY22 results...
Oct 25, 2021 07:00 ET
Allergy Therapeutics announces positive top line results from G309 exploratory field trial to evaluate efficacy and safety of Grass MATA MPL
Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”) Allergy Therapeutics announces positive top line results from G309 exploratory field trial to evaluate efficacy and safety of Grass MATA MPL Primary endpoint Combined...
Oct 25, 2021 07:00 ET
Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported biomarker data from a...
Oct 25, 2021 07:00 ET
Ascension provides a positive update on its intellectual property portfolio
Ascension provides a positive update on its intellectual property portfolio - Key patents granted by the European Patent Office - LONDON, October 25, Ascension Healthcare plc (“Ascension” or the “Company”), a clinical stage biopharmaceutical...
Oct 25, 2021 07:00 ET
Athabasca Oil Corporation Closes US$350 million Senior Secured Notes Financing, Enters into a C$110 million Credit Facility and Provides Strategic Update
Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) announces that it has closed the issuance of US$350 million of Senior Secured Notes and the syndication of a $110 million reserve based credit facility. Athabasca’s strategy is to...
Oct 25, 2021 07:00 ET
Autolus Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2021 financial results and operational highlights...
Oct 25, 2021 07:00 ET
Avenue Therapeutics Receives Interim Response to its Formal Dispute Resolution Request from U.S. Food and Drug Administration Office of New Drugs
Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced that it has received a written interim response from the Office of New Drugs (“OND”) of...
Oct 25, 2021 07:00 ET
Ceridian Named a Leader in the 2021 Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for Second Consecutive Year
Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM) technology, announced it has been named a Leader in the 2021 Gartner Magic Quadrant for Cloud HCM Suites for 1,000+ Employee Enterprises1. Ceridian was recognized...
Oct 25, 2021 07:00 ET
CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a new generation of its TRANBERG® Thermal Therapy System is being evaluated for MRI-US, fusion-guided...
Oct 25, 2021 07:00 ET
Copa Airlines introduces option for ConnectMiles members to multiply their miles, powered by Points International
Good news for Copa Airlines’ ConnectMiles members looking to maximize their miles as demand for travel increases. Just launched by Copa Airlines, one of the foremost airlines in Latin America, ConnectMiles Accelerator provides customers with the...
Oct 25, 2021 07:00 ET
Dorman Products, Inc. Reports Third Quarter Results
Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM), a leading supplier in the automotive aftermarket industry, today announced its financial results for the third quarter ended September 25, 2021. Third Quarter Financial ResultsDorman...
Oct 25, 2021 07:00 ET
ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock
Esperion (NASDAQ: ESPR) today announced that it has entered into a privately negotiated exchange agreement with two co-managed holders (the “Holders”) of its 4.00% Convertible Senior Subordinated Notes due 2025 (the "Notes"). Under the terms of the...
Oct 25, 2021 07:00 ET
FibroGen Announces Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2021
FibroGen, Inc. (NASDAQ: FGEN), today announced that analyses from the global Phase 3 roxadustat clinical program will be presented at the American Society of Nephrology Kidney Week 2021 taking place virtually November 4 - 7, 2021. A total of 18...
Oct 25, 2021 07:00 ET
Finch Therapeutics Presents Positive Data from PRISM3 Clinical Trial of CP101 for Recurrent C. difficile at American College of Gastroenterology Annual Scientific Meeting
Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today...
Oct 25, 2021 07:00 ET
First Advantage to Release Third Quarter 2021 Financial Results and Hold Investor Conference Call on November 8
First Advantage Corporation (NASDAQ: FA), a leading global provider of technology solutions for screening, verifications, safety and compliance related to human capital, will issue its third quarter 2021 financial results on Monday, November 8,...
Oct 25, 2021 07:00 ET
Genesis HealthCare, MAEVA and CEO Harry Wilson to Complete Engagement
Genesis Healthcare, Inc. (Genesis, or the Company) (OTC: GENN), a national post-acute care provider, announced today that Harry Wilson, the Company’s Chief Executive Officer (CEO), and his consulting firm, the MAEVA Group, provided notice that they...